1000 Cures
Accelerating parent-powered cures for rare pediatric diseases one family, one program, one cure at a time.
What is 1000 Cures?
First accelerator purpose-built for rare disease family founders, the most motivated operators in biopharma.
How does it work?
Resourcing lean startups to reach FDA approval on capital efficient, expedited timelines compared to industry average.
Why now?
To end pediatric rare disease and secure priority review vouchers, which typically sell for 100M – 200M USD.
English